Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration

Journal of Neurology

Volumn 255, Issue 4, 2008, Pages 539-544

  Galimberti, D ^a   Venturelli, E ^a   Fenoglio, C ^a   Guidi, I ^a   Villa, C ^a   Bergamaschini, L ^a   Cortini, F ^a   Scalabrini, D ^a   Baron, P ^a   Vergani, C ^a   Bresolin, N ^a   Scarpini, E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer's disease (AD); Cerebrospinal fluid (CSF); Cytokines; Frontotemporal lobar degeneration (FTLD); Interleukin 11 (IL 11)

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; INTERLEUKIN 11; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BIOLOGICAL MARKERS; DEMENTIA; FEMALE; HUMANS; INTERLEUKIN-11; INTERLEUKIN-6; INTERLEUKINS; LEUKEMIA INHIBITORY FACTOR; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; TAU PROTEINS; UP-REGULATION;

EID: 42549130059     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-008-0737-6     Document Type: Article

References (34)

1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21:383-421
2. Andreasen N, Blennow K (2005) CSF biomarkers for mild cognitive impairment and early Alzheimer's disease. Clin Neurol Neurosurg 107:165-173
3. Araujo DM, Cotman CW (1993) Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res 600:49-55
4. Blum-Degen D, Müller T, Kuhn W, Gerlach M, Przuntek H, Riederer P (1995) Interleukin-1 β and interleukin- 6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett 202:17-20
5. Fann MJ, Patterson PH (1994) Neuropoietic cytokines and activin A differentially regulate the phenotype of cultured symphatetic neurons. Proc Natl Acad Sci USA 91:43-47
6. Fenoglio C, Galimberti D, Lovati C, Guidi I, Gatti A, Fogliarino S, et al. (2004) MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels. Neurobiol Aging 25:1169-1173
7. Galimberti D, Schoonenboom N, Scarpini E, Scheltens P, on behalf of the Dutch-Italian Alzheimer Research Group (2003) Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients. Ann Neurol 53(4):547-548
8. Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Venturelli E, Pijnenburg YAL, et al. (2006) Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration. Neurology 66:146-147
9. Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Bouwman F, Venturelli E, et al. (2006) Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch Neurol 63(4):538-543
10. Heese K, Nagai Y, Tohru S (2000). Induction of rat L-phosphoserine phosphatase by amyloid-β (1-42) is inhibited by interleukin-11. Neurosci Lett 288:37-40
11. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with endspecific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13:45-53
12. Jia JP, Meng R, Sun YX, Sun WJ, Ji XM, Jia LF (2005) Cerebrospinal fluid tau, Ab 1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia. Neurosci Lett 383:12-16
13. Kalehua AN, Nagel JE, Whelchel LM, Gides JJ, Pyle RS, Smith RJ, et al. (2004) Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxininduced neurodegeneration and regeneration. Exp Cell Res 297:197-211
14. Leng SX, Elias JA (1997) Molecules in focus. Interleukin-11. Int J Biochem Cell. Biol 29:1059-1062
15. Markesbery WR, Schmitt FA, Kryscio RJ, Davis DG, Smith CD, Wekstein DR (2006) Neuropathologic substrate of mild cognitive impairment. Arch Neurol 63(1):38-46
16. März P, Heese K, Hock C, Golombowski S, Muller-Spahn F, Rose-John S, Otten U (1997) Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett 239:29-32
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944
18. Mehler MF, Rozental R, Dougherty M, Spray DC, Kesslerm JA (1993) Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature 362:62-65
19. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L (2001) Mild cognitive impairment represents early-stage Alzheimer's disease. Arch Neurol 58:397-405
20. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. (1998) Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology 51:1546-1554
21. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303-308
22. Richartz E, Stransky E, Batra A, Simon P, Lewczuk P, Buchkremer G, et al. (2005) Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease? J Psychiatr Res 39(5):535-543
23. Sellebjerg F, Christiansen M (1996) Qualitative assessment of intrathecal IgG synthesis by isoelectric focusing and immunodetection: interlaboratory reproducibility and interobserver agreement. Scand J Clin Lab Invest 56:135-143
24. Simon R, Thier M, Kruttgen A, Rose- John S, Weiergraber O, Heinrich PC, et al. (1995) Human CNTF and related cytokines: effects on DRG neurone survival. Neuroreport 7:153-157
25. Sjögren M, Folkesson S, Blennow K, Tarkowski E (2004) Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications. J Neurol Neurosurg Psychiatry 75:1107-1111
26. Taga T, Kishimoto T (1997) Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15:797-819
27. Tarkowski E, Wallin A, Blennow K, Tarkowski A (1999) Intracerebral production of tumor necrosis factoralpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol 19:223-230
28. Tarkowski E, Liljeroth AM, Minthon L, Tarkowski A, Wallin A, Blennow K (2003) Cerebral pattern of pro- and anti-inflammatory cytokines in dementias. Brain Res Bull 61(3):255-260
29. The Italian Longitudinal Study on Aging (1997) Prevalence of chronic diseases in older Italians: comparing self-reported and clinical diagnosis. Internat J Epidemiol 26:995-1002
30. Thier M, Hall M, Heath JK, Pennica D, Weis J (1999) Trophic effects of cardiotrophin- 1 and interleukin-11 on rat dorsal root ganglion neurons in vitro. Mol Brain Res 64:80-84
31. Wada-Isoe K, Wakutani Y, Urakami K, Nakashima K (2004) Elevated interleukin- 6 levels in cerebrospinal fluid of vascular dementia patients. Acta Neurol Scand 110:124-127
32. Xia MQ, Hyman BT (1999) Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J Neurovirol 5:32-41
33. Yamada K, Kono K, Umegaki H, Yamada K, Iguchi A, Fukatsu T, et al. (1995) Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia. Neurosci Lett 186:219-221
34. Yang, YC (1993) Interleukin 11: an overview. Stem Cells 11:474-486